BioTwin describes a broad molecular reading of more than 30,000 biomarker-derived metabolic signals. In untargeted metabolomics, a detected signal is not necessarily a separately identified metabolite. Several signals may relate to one molecule, and some remain unassigned.
This does not mean 30,000 clinical tests or 30,000 independently validated biomarkers. Identification, analytical reliability and clinical interpretation are distinct steps.
The research value lies in patterns, their reproducibility and how they vary over time. Repeated samples can be studied alongside lifestyle context and wearable data. The meaning of a pattern must be validated for the specific question being asked.
Routine blood tests remain useful for their established clinical indications. A broader research measurement complements a different question; the number of signals alone does not establish better diagnosis.
Sources and scope
Important: This article may discuss BioTwin research, medical vision, regulated clinical pathways, or TwinMe wellness education. TwinMe wellness outputs are not medical or laboratory tests. BioTwin clinical outputs are available only where authorized and through licensed healthcare professionals.